Techinnovation.pro — Technology, Innovation & IP Advisory
Technology & Innovation Advisory

Technology becomes an asset when the right decisions are made around it

We help technology companies and investors make stronger decisions around innovation, protection, trust and risk

16+ years · 1 000+ patents · 350+ technology research projects · $500M+ asset value context

For Founders & Technology Companies

When technology, ownership or trust may become a business problem

  • Investors ask about IP and rights — you lack clear answers
  • Enterprise clients require GDPR / ISO / security evidence
  • A key person left and code ownership is unclear
  • Competitors copy core product ideas with no defense in place
  • Development direction may be blocked by restrictions you haven't mapped
See what we clarify
For Investors & Funds

When technology risk may affect price, terms or IC decision

  • The story is compelling but you need to test the actual asset
  • Scaling risks are unclear and could become expensive post-deal
  • You enter IC without technical facts that could change the price
  • A strong asset may be underestimated by standard review
  • You need specific questions to ask the founder before committing
See what we clarify
Founder advisory

Where technology companies lose strength

These problems surface at the next round, enterprise review or transaction — when fixing them is expensive

Investor review pressure

No order in IP and ownership. Every investor question exposes gaps you cannot close quickly

Enterprise trust gap

Clients ask for GDPR, ISO, security evidence. Without it, enterprise deals stall or disappear

Ownership chaos

Key person leaves, contractor disputes rights. Code, data and know-how ownership is undocumented

Copying by competitors

Core product ideas replicated. No structured protection means no defense and no negotiation leverage

Claims and conflicts

A letter, threat or blocking risk appears. The cost of resolution is already high by the time you learn about it

Wrong development direction

Technology restrictions or competitor positions should have changed the roadmap — discovered too late

After we work together

What we help founders clarify

What should be protected

Which algorithms, data methods and technologies have real defensible value

What should be formalized

Code ownership, contractor IP, know-how boundaries, employee contributions

Which directions are safe or risky

Where competitor positions, technology restrictions or market limits constrain your roadmap

What triggers investor or enterprise questions

Specific gaps that raise red flags during due diligence or enterprise review

What to fix first

Priority order: ownership gaps, compliance needs, competitive vulnerabilities

What becomes a real technology asset

R&D converted into protected, transferable business value — not just product code

Free founder review call

30 minutes. We identify the first risks, what may be worth protecting, and whether deeper review is needed

Investor advisory

Where investors lose returns

The cost of a technology misjudgment rises after IC — when price, terms and structure are already committed

Compelling story, weaker asset

Strong pitch, growing revenue — but core technology is unprotected, easy to replicate or built on restrictive open-source

Strong asset underestimated

Complex technology, unclear communication — but the real defensibility and upside are missed by standard review

Scaling risks missed

Technology works at current scale but faces licensing, architecture or market constraints that block growth

Wrong entry price

Valuation reflects a growth story, not the actual strength or vulnerability of the technology position

Weak negotiation position

Without specific technical facts, the fund cannot negotiate from strength on price, milestones or protection clauses

Expansion potential missed

The asset has defensible positions in adjacent markets or use cases that neither the fund nor the founder has identified

What changes after we work together

What we help investors clarify before IC

Whether the asset is stronger or weaker than it appears

Real defensibility vs. surface-level claims, tested against competitive landscape

Which technology risks affect price or terms

Specific risks that should change valuation, deal structure or milestone conditions

Which questions to ask the founders

Targeted questions based on technology analysis, not generic due diligence checklists

Whether the roadmap supports the investment thesis

Does the planned development direction align with what the technology landscape actually allows

Where hidden upside may exist

Defensible positions in adjacent markets or use cases not visible from standard review

Whether to go deeper, change terms or pause

Clear recommendation: proceed, adjust price/terms, request a deeper screen, or pass

Free investor review call

30 minutes. We discuss one active deal, identify obvious risk areas, and decide whether a quick screen or IC-ready memo is needed

differentiator

Technology intelligence before expensive decisions

Sometimes the strongest move is not to protect the current path, but to change direction in time

What competitors already protect

Existing technology restrictions, protected solutions and areas where the landscape is closed

Where development may be restricted

Competitive constraints, licensing limitations or market restrictions that may block product growth

Where open space remains

Defensible development paths where innovation can be protected, scaled and monetized

Which product branches limit growth

Directions that may create ownership risks, restrict sales or conflict with competitor positions

When changing direction is better

Evidence-based assessment of whether the current path is worth defending or a pivot creates more value

How this affects the deal or the round

For founders: stronger investor story. For investors: clearer asset strength assessment before IC

Selected work

How stronger decisions change outcomes

Founder case

AI / SaaS

Situation

Series A company needed to know whether its core algorithm was defensible before approaching growth investors

What changed

Direction shifted to a novel, unprotected data processing method. Protection filed. Investor materials restructured around the stronger asset

Business effect

Defensible technology story for investor conversations. Reduced exposure in weaker areas

Founder case

Cybersecurity

Situation

Preparing for enterprise sales, found key features built by contractors with no IP assignment

What changed

Ownership restructured, contracts corrected, enterprise trust framework established

Business effect

Passed first enterprise security review. Closed two large contracts within six months

Investor case

Growth-stage Fintech

Situation

Fund evaluating a Series B fintech at premium valuation. Company claimed proprietary transaction processing

What changed

Core logic based on open-source with restrictive licenses. Two key innovations unprotected and easily replicable

Business effect

Offer adjusted to reflect actual defensibility. IP protection milestones negotiated as deal conditions

About the practice

Built on deep technology immersion

Independent technology, innovation and IP advisory. We work where technology direction, asset protection, competitive intelligence and investment risk intersect

Across 350+ research projects and 1 000+ patents filed globally, we see where technology positions are strong, where they are vulnerable, and where real value sits

Domains: AI, cybersecurity, cloud, telecom, fintech, biometrics, autonomous systems, SaaS. Network of specialized experts in IP, legal, privacy and compliance

16+
Years of technology
and IP expertise
1 000+
Patents across
US / EU / China / Russia
350+
Technology
research projects
$500M+
Asset value
context

Questions we hear often

No. Patents are one tool. The real value is broader: ownership clarity, competitive positioning, trust frameworks, technology direction and risk reduction

If you have a working product and decisions to make about direction or protection — no. The earlier you build the right structure, the cheaper it is to fix

We do not raise capital. We prepare the technology and IP layer so that when investors ask hard questions, you have defensible answers

Yes. Enterprise buyers require GDPR, ISO and maturity evidence. We build it before the opportunity requires it

We focus on strategic positioning and risk, not on freezing the product. Output stays relevant as the product evolves

No. We strengthen the technology and IP layer, which makes investor conversations more productive

We use AI where it adds value. But judgment across hundreds of real projects and translating findings into business language requires human expertise

Brief product description, technology stack overview, and any specific questions. No formal package required

Regular due diligence answers "what exists now." We answer "how strong is this asset, what risks are hidden, and what does it mean for your deal." Decision layer, not code audit

No. We assess defensibility, identify hidden risks and underestimated potential, and translate that into investment consequences

Assessing real technology risk and translating it into fund language requires experience across hundreds of transactions. AI accelerates research; it does not replace judgment

Before IC, when the fund still has leverage on price, terms and structure. Post-term-sheet is possible but reduces strategic value

Clearer view of the asset. Specific questions for the founder. Risk-adjusted perspective that may affect valuation, terms or go/no-go

Yes. We support portfolio companies with technology direction, IP structuring and enterprise readiness

Strict NDA from day one. No deal information shared with any third party

Quick Risk Screen: ~5 days. IC-Ready Memo: 12–15 days. Written assessment, findings walkthrough on a call. Pricing is project-based

Start here

Start with one technology decision

Send a deck, site or product description. We will use the free call to identify the first risks, questions and possible next steps

No commitment required. In 30 minutes we cover the first risks, priorities and whether deeper work makes sense